• About Us
  • Our Team
  • Advertising
  • Careers
  • Contact
Tuesday, June 10, 2025
  • Login
No Result
View All Result
Navjeevan Express
Advertisement
  • Gujarat
    • Ahmedabad
    • Vadodara
    • Surat
    • Rajkot
    • Saurashtra
    • Kutch
    • Central Gujarat
    • South Gujarat
  • National
    • Andhra Pradesh
    • Rajasthan
    • Maharashtra
    • Pondicherry
    • Tamil Nadu
    • OTHER STATES
  • Politics
  • Business
    • Companies
    • Personal Finance
  • Sports
    • Cricket
    • Hockey
    • Football
    • Badminton
    • Other Sports
  • Entertainment
    • Arts and Culture
    • Theatre
    • Cinema
    • Photos
    • Videos
  • Lifestyle
    • Fashion
    • Health & Environment
    • Food and Beverages
    • Spirituality
    • Tourism and Travel
  • World
  • More
    • Science and Technology
    • Legal
    • Opinion
    • Student’s Corner
    • Youth
Navjeevan Express
  • Gujarat
    • Ahmedabad
    • Vadodara
    • Surat
    • Rajkot
    • Saurashtra
    • Kutch
    • Central Gujarat
    • South Gujarat
  • National
    • Andhra Pradesh
    • Rajasthan
    • Maharashtra
    • Pondicherry
    • Tamil Nadu
    • OTHER STATES
  • Politics
  • Business
    • Companies
    • Personal Finance
  • Sports
    • Cricket
    • Hockey
    • Football
    • Badminton
    • Other Sports
  • Entertainment
    • Arts and Culture
    • Theatre
    • Cinema
    • Photos
    • Videos
  • Lifestyle
    • Fashion
    • Health & Environment
    • Food and Beverages
    • Spirituality
    • Tourism and Travel
  • World
  • More
    • Science and Technology
    • Legal
    • Opinion
    • Student’s Corner
    • Youth
No Result
View All Result
Navjeevan Express
No Result
View All Result
ADVERTISEMENT
Home National Gujarat Ahmedabad

Zydus gets final nod from USFDA for Scopolamine Transdermal System 1 mg/3 days

by Nav Jeevan
9 months ago
in Ahmedabad, America, Ayush, Breaking News, Business, COVID-19, Gujarat, Health & Environment, Hospitals, National, Pharma
Reading Time: 1 min read
0
0
Zydus gets final nod from USFDA for Scopolamine Transdermal System 1 mg/3 days
ADVERTISEMENT
  • This is the fifth ANDA approval for Zydus in the transdermal portfolio, leveraging the group’s strengths in the manufacturing of complex drug device dosage forms
  • This will be produced at the group’s transdermal manufacturing site at SEZ, Matoda, Ahmedabad.

NE BUSINESS BUREAU

AHMEDABAD, AUGUST 31

Zydus Lifesciences Limited on Friday announced that it has received final approval from the United States Food and Drug Administration (USFDA) to market Scopolamine Transdermal System 1 mg/3 days. (USRLD: Transderm Scop Transdermal System ® 1 mg/3 days). This is the fifth ANDA approval for Zydus in the transdermal portfolio, leveraging the group’s strengths in the manufacturing of complex drug device dosage forms.

Scopolamine Transdermal System is indicated to prevent nausea and vomiting after anaesthesia, narcotic pain medicines, and surgery. It is also used to prevent nausea and vomiting caused by motion sickness. The Scopolamine Transdermal System will be produced at the group’s transdermal manufacturing site at SEZ, Matoda, Ahmedabad.

Scopolamine Transdermal System 1 mg/3 days had annual sales of USD $69.6 mn in the United States (IQVIA MAT June 2024).

The group now has 400 approvals and has so far filed over 465 as of 30th June 2024 ANDAs since the commencement of the filing process in FY 2003-04.

Tags: 1 mg/3 daysfinal nodgetsScopolamine Transdermal SystemScotemusfdaZydus
ADVERTISEMENT
Previous Post

Tamil Nadu cadre IAS officer Dr. T.V. Somanathan takes over as new Cabinet Secy

Next Post

India’s most violent film, Kill set to premiere on Disney+ Hotstar on Friday, 6th Sept

Nav Jeevan

Nav Jeevan

Next Post
India’s most violent film, Kill set to premiere on Disney+ Hotstar on Friday, 6th Sept

India’s most violent film, Kill set to premiere on Disney+ Hotstar on Friday, 6th Sept

GIFT Nifty sets an all-time high open interest of US $18.29 bn on Aug 27

GIFT Nifty sets an all-time high open interest of US $18.29 bn on Aug 27

ADVERTISEMENT

Recommended

Infibeam Avenues expands global foothold with 20% strategic stake in US-based XDuce

Infibeam Avenues expands global foothold with 20% strategic stake in US-based XDuce

1 year ago
Paytm brings lightning fast payments that never fail — up to ₹200 in one tap with UPI LITE

Paytm brings lightning fast payments that never fail — up to ₹200 in one tap with UPI LITE

2 years ago
ADVERTISEMENT

Recent Posts

  • Double lung transplant at Rela Hospital breathes new life into mother of 2 angels, and averts heart transplant
  • DRDO transfers 9 defence system technologies to 10 industry partners in public, pvt sectors
  • A childhood among cliffs and Vikings: The true story behind – ‘How to Train Your Dragon’

Category

Select Category

    Contact Us

    Email:
    ne.gowri1964@gmail.com

    Phone:
    9643255068

    Live Visitors

    • About Us
    • Our Team
    • Advertising
    • Careers
    • Contact

    © 2021 all right reserved by Navjeevanexpress.com. Consulted by MediaHives.com

    No Result
    View All Result
    • Gujarat
      • Ahmedabad
      • Vadodara
      • Surat
      • Rajkot
      • Saurashtra
      • Kutch
      • Central Gujarat
      • South Gujarat
    • National
      • Andhra Pradesh
      • Rajasthan
      • Maharashtra
      • Pondicherry
      • Tamil Nadu
      • OTHER STATES
    • Politics
    • Business
      • Companies
      • Personal Finance
    • Sports
      • Cricket
      • Hockey
      • Football
      • Badminton
      • Other Sports
    • Entertainment
      • Arts and Culture
      • Theatre
      • Cinema
      • Photos
      • Videos
    • Lifestyle
      • Fashion
      • Health & Environment
      • Food and Beverages
      • Spirituality
      • Tourism and Travel
    • World
    • More
      • Science and Technology
      • Legal
      • Opinion
      • Student’s Corner
      • Youth

    © 2021 all right reserved by Navjeevanexpress.com. Consulted by MediaHives.com

    Welcome Back!

    Login to your account below

    Forgotten Password?

    Retrieve your password

    Please enter your username or email address to reset your password.

    Log In